Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Releases Guidance Documents On PMA, 510(k) Review Times And Goals

This article was originally published in The Gray Sheet

Executive Summary

The agency outlined how it plans to calculate review times and meet performance goals for PMA and 510(k) submissions in two recent guidance documents.

Advertisement

Related Content

FDA Outlines Mandated eCopy Submission Program In Draft Guidance
Final FDA Bill: Device Provisions
Device Industry Expects Quicker Path To Market In Exchange For Doubling Of User Fees
FDA Embraces Total-Time Pre-Market Review Goals, With Shared Accountability

Topics

Advertisement
UsernamePublicRestriction

Register

MT031667

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel